Search results
Found 10585 matches for
Group of Professor Kristijan Ramadan has published an original scientific article in Nature Communications today. The article has the first report of a new autophagy receptor TEX264, which may be involved in tumours developing drug resistance.
LungVax
LungVax: A Phase I Dose-escalation and Phase II Precision-Prevention trial of ChAdOx2-lungvax-NYESO vaccination for patients at risk of new or recurrent non-small cell lung cancer (NSCLC
Advancing CLL Management
This is a continuing professional development course promoting state of the art Chronic Lymphocytic Leukaemia diagnosis, management, and clinical research globally. This course is run in partnership with the International Workshop on Chronic Lymphocytic Leukemia (iwCLL).
Welcome
The Department of Oncology's mission is to improve cancer care through research and teaching. There is strong emphasis on translation, with established infrastructure to develop scientific insights toward clinical appreciation.